[1]
|
Clarke, P.H. and Richmond M.H. (1975) Genetics and Biochemistry of Pseudomonas. John Wiley and Sons, London.
|
[2]
|
Cornelis, P. (Ed.) (2008) Pseudomonas: Genomics and Molecular Biology. Caister Academic Press, Belgium.
|
[3]
|
Krylov, V.N. (2001) Phagotherapy in Terms of Bacteriophage Genetics: Hopes, Perspectives, Safety, Limitations. Russian Journal of Genetics, 37, 715-730. http://dx.doi.org/10.1023/A:1016716606135
|
[4]
|
Kutter, E. and Sulakvelidze, A. (Eds.) (2005) Bacteriophages—Biology and Application. CRC Press, Boca Raton.
|
[5]
|
Merabishvili, M., Pirnay, J.P., Verbeken, G., Chanishvili, N., Tediashvili, M., Lashkhi, N., Glonti, T., Krylov, V., Mast, J., Van Parys, L., Lavigne, R., Volckaert, G., Mattheus, W., Verween, G., De Corte, P., Rose, T., Jennes, S., Zizi, M., De Vos, D. and Vaneechoutte, M. (2009) Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials. PLoS ONE, 4, Article ID: e4944.
http://dx.doi.org/10.1371/journal.pone.0004944
|
[6]
|
Krylov, V., Shaburova, O., Krylov, S. and Pleteneva, E. (2013) A Genetic Approach for Development of New Therapeutic Phages to Fight Pseudomonas Aeruginosa in Wound Infections. Viruses, 5, 15-53.
http://dx.doi.org/10.3390/v5010015
|
[7]
|
Chan, B.K., Abedon, S.T. and Loc-Carrillo, C. (2013) Phage Cocktails and the Future of Phage Therapy. Future Microbiology, 8, 769-783. http://dx.doi.org/10.2217/fmb.13.47
|
[8]
|
Chanishvili, N. (2012) Phage Therapy—History from Twort and d’Herelle Through Soviet Experience to Current Approaches. Advances in Virus Research, 83, 3-40. http://dx.doi.org/10.1016/B978-0-12-394438-2.00001-3
|
[9]
|
Krylov, V.N. (2014) Bacteriophages of Pseudomonas aeruginosa: Long-Term Prospects for Use in Phage Therapy. Advances in Virus Research, 88, 227-278. http://dx.doi.org/10.1016/B978-0-12-800098-4.00005-2
|
[10]
|
Skurnik, M. and Strauch, E. (2006) Phage therapy: Facts and Fiction. International Journal of Medical Microbiology, 296, 5-14. http://dx.doi.org/10.1016/j.ijmm.2005.09.002
|
[11]
|
Brüssow, H. (2012) What Is Needed for Phage Therapy to Become a Reality in Western Medicine? Virology, 434, 138-142. http://dx.doi.org/10.1016/j.virol.2012.09.015
|
[12]
|
Fortier, L.C. and Sekulovic, O. (2013) Importance of Prophages to Evolution and Virulence of Bacterial Pathogens. Virulence, 4, 354-365. http://dx.doi.org/10.4161/viru.24498
|
[13]
|
Krylov, V.N., Tolmachova, T.O. and Akhverdian, V.Z. (1993) DNA Homology in Species of Bacteriophages Active on Pseudomonas aeruginosa. Archives of Virology, 131, 141-151. http://dx.doi.org/10.1007/BF01379086
|
[14]
|
NCBI GenBank. http://www.ncbi.nlm.nih.gov/genbank/
|
[15]
|
McCallum, S.J., Gallagher, M.J., Corkill, J.E., Hart, C.A., Ledson, M.J. and Walshaw, M.J. (2002) Spread of an Epidemic Pseudomonas aeruginosa Strain from a Patient with Cystic Fibrosis (CF) to Non-CF Relatives. Thorax, 57, 559-560. http://dx.doi.org/10.1136/thorax.57.6.559
|
[16]
|
Armstrong, D.S., Nixon, G.M., Carzino, R., Bigham, A., Carlin, J.B., Robins-Browne, R.M. and Grimwood, K. (2002) Detection of a Widespread Clone of Pseudomonas aeruginosa in a Pediatric Cystic Fibrosis Clinic. American Journal of Respiratory and Critical Care Medicine, 166, 983-987.
|
[17]
|
Panagea, S., Winstanley, C., Walshaw, M.J., Ledson M.J. and Hart C.A. (2005) Environmental Contamination with an Epidemic Strain of Pseudomonas aeruginosa in a Liverpool Cystic Fibrosis Centre, and Study of Its Survival on Dry Surfaces. Journal of Hospital Infection, 59, 102-107. http://dx.doi.org/10.1016/j.jhin.2004.09.018
|
[18]
|
Winstanley, C., Langille, M.G.I., Fothergill, J.L., Kukavica-Ibrulj, I., Paradis-Bleau, C., Sanschagrin, Fo., Thomson, N.R., Winsor, G.L., Quail, M.A. and Lennard, N. (2009) Newly Introduced Genomic Prophage Islands Are Critical Determinants of in Vivo Competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Research, 19, 12-23. http://dx.doi.org/10.1101/gr.086082.108
|
[19]
|
Shabalova, L.A., Kapranov, N.I., Krylov, V.N. and Solovieva, T.I. (1993) Pseudomonas aeruginosa Bacteriophages in Treatment of Pseudomonas aeruginosa Infection in CF. 7th Annual North American Cystic Fibrosis Conference, Dallas, Texas, 13-16 October 1993, 264.
|
[20]
|
Golshahi, L., Lynch, K.H., Dennis, J.J. and Finlay, W.H. (2011) In Vitro Lung Delivery of Bacteriophages KS4-M and ФKZ Using Dry Powder Inhalers for Treatment of Burkholderia cepacia Complex and Pseudomonas aeruginosa Infections in Cystic Fibrosis. Journal of Applied Microbiology, 110, 106-117.
http://dx.doi.org/10.1111/j.1365-2672.2010.04863.x
|
[21]
|
Lynch, K.H. and Dennis, J.J. (2012) Cangene Gold Medal Award Lecture—Genomic Analysis and Modification of Burkholderia cepacia Complex Bacteriophages. Canadian Journal of Microbiology, 58, 221-235.
http://dx.doi.org/10.1139/w11-135
|
[22]
|
Vandenheuvel, D., Singh, A., Vandersteegen, K., Klumpp, J., Lavigne, R. and Van den Mooter, G. (2013) Feasibility of Spray Drying Bacteriophages into Respirable Powders to Combat Pulmonary Bacterial Infections. European Journal of Pharmaceutics and Biopharmaceutics, 84, 578-582. http://dx.doi.org/10.1016/j.ejpb.2012.12.022
|
[23]
|
Alemayehu, D., Casey, P.G., McAuliffe, O., Guinane, C.M., Martin, J.G., Shanahan, F., Coffey, A., Ross, R.P. and Hill, C. (2012) Bacteriophages ΦMR299-2 and ΦNH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells. mBio, 3, Article ID: e00029-12. http://dx.doi.org/10.1128/mBio.00029-12
|
[24]
|
Henry, M., Lavigne, R. and Debarbieux, L. (2013) Predicting in Vivo Efficacy of Therapeutic Bacteriophages Used to Treat Pulmonary Infections. Antimicrobial Agents and Chemotherapy, 12, 5961-5968.
http://dx.doi.org/10.1128/AAC.01596-13
|
[25]
|
Krylov, V.N. and Zhazykov, I.Zh. (1978) Pseudomonas Bacteriophage phiKZ—Possible Model for Studying the Genetic Control of Morphogenesis. Genetika, 14, 678-685.
|
[26]
|
Krylov, V.N., Smirnova, T.A., Minenkova, I.B., Plotnikova, T.G., Zhazikov, I.Z. and Khrenova, E.A. (1984) Pseudomonas Bacteriophage phiKZ Contains an Inner Body in its Capsid. Canadian Journal of Microbiology, 30, 758-762.
http://dx.doi.org/10.1139/m84-116
|
[27]
|
Mesyanzhinov, V.V., Robben, J., Grymonprez, B., Kostyuchenko, V.A., Bourkaltseva, M.V., Sykilinda, N.N., Krylov, V.N. and Volckaert, G. (2002) The Genome of Bacteriophage phiKZ of Pseudomonas aeruginosa. Journal of Molecular Biology, 317, 1-19. http://dx.doi.org/10.1006/jmbi.2001.5396
|
[28]
|
Hertveldt, K., Lavigne, R., Pleteneva, E., Sernova, N., Kurochkina, L., Korchevskii, R., Robben, J., Mesyanzhinov, V., Krylov, V.N. and Volckaert, G. (2005) Genome Comparison of Pseudomonas aeruginosa Large Phages. Journal of Molecular Biology, 354, 536-545.
|
[29]
|
Pleteneva, E.A., Krylov, S.V., Shaburova, O.V., Burkal’tseva, M.V., Miroshnikov, K.A. and Krylov, V.N. (2010) Pseudolysogeny of Pseudomonas aeruginosa Bacteria Infected with phiKZ-Like Bacteriophages. Russian Journal of Genetics, 46, 20-25. http://dx.doi.org/10.1134/S1022795410010047
|
[30]
|
Krylov, S.V., Pleteneva, E.A., Bourkaltseva, M.V., Shaburova, O.V., Miroshnikov, K.A., Lavigne, R., Cornelissen, A. and Krylov, V.N. (2011) Genome Instability of Pseudomonas aeruginosa Phages of the EL Species: Examination of Virulent Mutants. Russian Journal of Genetics, 47, 162-167. http://dx.doi.org/10.1134/S1022795411020116
|
[31]
|
Lavigne, R., Burkal’tseva, M.V., Robben, J., Sykilinda, N.N., Kurochkina, L.P., Grymomprez, B., Jonckx, B., Krylov, V.N., Mesyanzhinov, V.V. and Volckaert, G. (2003) The Genome of Bacteriophage phiKMV, a T7-Like Virus Infecting Pseudomonas aeruginosa. Virology, 312, 49-59.
|
[32]
|
Ceyssens, P.J., Glonti, T., Kropinski, N.M., Lavigne, R., Chanishvili, N., Kulakov, L., Lashkhi, N., Tediashvili, M. and Merabishvili, M. (2011) Phenotypic and Genotypic Variations Within a Single Bacteriophage Species. Virology Journal, 8, 134. http://dx.doi.org/10.1186/1743-422X-8-134
|
[33]
|
Pleteneva, E.A., Shaburova, O.V., Sykilinda, N.N., Miroshnikov, K.A., Krylov, S.V., Mesianzhinov, V.V. and Krylov, V.N. (2008) Study of the Diversity in a Group of Phages of Pseudomonas aeruginosa Species PB1 (Myoviridae) and Their Behavior in Adsorbtion-Resistant Bacterial Mutants. Russian Journal of Genetics, 44, 185-194.
http://dx.doi.org/10.1134/S1022795408020051
|
[34]
|
Ceyssens, P.J., Miroshnikov, K., Mattheus, W., Krylov, V., Robben, J., Noben, J.P., Vanderschraeghe, S., Sykilinda, N., Kropinski, A.M., Volckaert, G., Mesyanzhinov, V. and Lavigne, R. (2009) Comparative Analysis of the Widespread and Conserved PB1-Like Viruses Infecting Pseudomonas aeruginosa. Environmental Microbiology, 11, 2874-2883. http://dx.doi.org/10.1111/j.1462-2920.2009.02030.x
|
[35]
|
Tan, Y., Zhang, K., Rao, X., Jin, X., Huang, J., Zhu, J., Chen, Z., Hu, X., Shen, X., Wang, L. and Hu, F. (2007) Whole Genome Sequencing of a Novel Temperate Bacteriophage of P. aeruginosa: Evidence of tRNA Gene Mediating Integration of the Phage Genome into the Host Bacterial Chromosome. Cellular Microbiology, 9, 479-491.
http://dx.doi.org/10.1111/j.1462-5822.2006.00804.x
|
[36]
|
Ceyssens, P.J., Hertveldt, K., Ackermann, H.W., Noben, J.P., Demeke, M., Volckaert, G. and Lavigne, R. (2008) The Intron-Containing Genome of the Lytic Pseudomonas phage LUZ24 Resembles the Temperate Phage PaP3. Virology, 377, 233-238. http://dx.doi.org/10.1016/j.virol.2008.04.038
|
[37]
|
Krylov, S.V., Kropinski, A.M., Pleteneva, E.A., Shaburova, O.V., Burkal’tseva, M.V., Miroshnikov, K.A. and Krylov, V.N. (2012) Properties of the New D3-Like Pseudomonas aeruginosa Bacteriophage phiPMG1: Genome Structure and Prospects for the Use in Phage Therapy. Russian Journal of Genetics, 48, 902-911.
http://dx.doi.org/10.1134/S1022795412060087
|
[38]
|
Kropinski, A.M. (2000) Sequence of the Genome of the Temperate, Serotype-Converting Pseudomonas aeruginosa Bacteriophage D3. Journal of Bacteriology, 182, 6066-6074. http://dx.doi.org/10.1128/JB.182.21.6066-6074.2000
|
[39]
|
Jeon, J., Kim, J.W., Yong, D., Lee, K. and Chong, Y. (2012) Complete Genome Sequence of the Bacteriophage YMC01/01/P52 PAE BP, Which Causes Lysis of Verona Integron-Encoded Metallo-β-Lactamase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa. Journal of Virology, 86, 13876-13877.
http://dx.doi.org/10.1128/JVI.02730-12
|
[40]
|
Burkal’tseva, M.V., Krylov, S.V., Kropinski, A.M., Pletneva, E.A., Shaburova, O.V. and Krylov, V.N. (2011) Bacteriophage phi297—The New Species of Temperate Phages Pseudomonas aeruginosa with a Mosaic Genome: Potential Use in Phagotherapy. Russian Journal of Genetics, 47, 794-798. http://dx.doi.org/10.1134/S102279541106007X
|
[41]
|
Krylov, S.V., Kropinski, A.M., Shaburova, O.V., Miroshnikov, K.A., Chesnokova, E.N. and Krylov, V.N. (2013) New Temperate Pseudomonas aeruginosa Phage, phi297: Specific Features of Genome Structure. Russian Journal of Genetics, 49, 806-818. http://dx.doi.org/10.1134/S1022795413080073
|
[42]
|
Latino, L., Essoh, C., Blouin, Y., Vu Thien, H. and Pourcel, C. (2014) A Novel Pseudomonas aeruginosa Bacteriophage, Ab31, a Chimera Formed from Temperate Phage PAJU2 and P. putida Lytic Phage AF: Characteristics and Mechanism of Bacterial Resistance. PLoS ONE, 9, Article ID: e93777.
http://dx.doi.org/10.1371/journal.pone.0093777
|
[43]
|
Kim, S., Rahman, M., Seol, S.Y., Yoon, S.S. and Kim, J. (2012) Pseudomonas aeruginosa Bacteriophage PA1Φ Requires Type IV Pili for Infection and Shows Broad Bactericidal and Biofilm Removal Activities. Applied and Environmental Microbiology, 78, 6380-6385. http://dx.doi.org/10.1128/AEM.00648-12
|
[44]
|
Ahiwale, S., Tamboli, N., Thorat, K., Kulkarni, R., Ackermann, H. and Kapadnis, B. (2011) In Vitro Management of Hospital Pseudomonas aeruginosa Biofilm Using Indigenous T7-Like Lytic Phage. Current Microbiology, 62, 335-340.
http://dx.doi.org/10.1007/s00284-010-9710-6
|